3. Peters - Hyperlipidemia Flashcards

(39 cards)

1
Q

Signs and Symptoms of Hyperlipidemia

A
  • Typically asymptomatic until a CV events occurs
  • Pancreatitis: directly related to high TGs, >500
  • Chest pain: clot in chest, MI or angina
  • Shortness of breath: clot moves into lungs
  • Speech or movement impaired: clot in brain (stoke)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Dyslipidemia?

A
  • A combination of elevated TC, elevated TGs, elevated LDL cholesterol, and low HDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the risk equivalents for coronary heart disease?

Hint, there’s 5

A
  1. Diabetes
  2. PAD
  3. CAD - MI or angina
  4. Abdominal aortic aneurysm (triple A syndrome)
  5. Framingham risk >20%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some major CV risk factors?

Hint, there’s 5

A
  1. Cigarette smoking
  2. Hypertension, BP >140/90
  3. Low HDL
  4. Family history of premature CHD
  5. Age, men >45 and women >55
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the target numbers based on ATP III?

A

TC: 40 mg/dL
TGs:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-Pharm Therapy for Hyperlipidemia

A
  • Diet counseling
  • Weight management
  • Increased physical activity
  • Smoking cessation
  • Hypertension treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Peters - MOA of statins

A
  • HMG-CoA Reductase inhibitor
  • Decrease cholesterol synthesis, lowers intracellular cholesterol which stimulates up regulation of LDL receptors increasing the intake of LDL, and lowering circulating LDL levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pleiotropic effects of statins

A

Help decrease plaque and clot formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the two high intensity statins and what are their available strengths?

A
  1. Atorvastatin, 40-80mg

2. Rosuvastatin, 20-40mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 main statin drug interactions to avoid?

A
  1. CCB (nondihydropyridines)
  2. Gemfibrozil
  3. Grapefruit juice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the main adverse effects of statins?

A
  • Headache and GI intolerance
  • Myalgia, which can lead to myopathy and/or rhabdomyolysis
  • New onset diabetes
  • Potential increase in LFTs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Managing statin therapy - how to determine if a pt is “intolerant”

A

Try 3 statins, 3 different times, at three different strengths.
If a pt does not respond, then they are considered statin intolerant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Peters - Fibrates and their MOA

A

Fenofibrate and Gemfibrozil

  • Agonist of proliferator-activated receptor-alpha
  • inhibit TG synthesis, increase LPL activity, increase breakdown of VLDL and increase HDL synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the net effect of statins?

A

Decreased TC

Decreased LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the net effect of Fibrates?

A

Significantly decreased TGs –> main effect
Decreased TC
Decreased LDL
Increased HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main adverse effects of Fibrates?

A
  • GI complaints
  • Changes in LFTs
  • Hypoglycemic effects in pts on sulfonureas
  • Renal dysfunction
    MAIN: Gemfibrozil inhibits break down of statins
17
Q

Examples of Bile Acid Sequestrants and their MOA

A

Cholestyramine, colestipol, colesevelam

MOA: Block the reabsorption of bile acids back into the liver, allows for easy excretion out through feces

18
Q

What is the net effect of bile acid sequestrants?

A

Decreased TC

Decreased LDL

19
Q

What are the main adverse effects of bile acid sequestrants?

A
  • GI distress
  • Potential increase in TG, should not be taken when pt >300 mg/dL
  • Impaired fat soluble vitamin absorption
  • Reduced bioavailability of other meds, separated dosing is needed
20
Q

What is Niacin’s MOA?

A

Decreased hepatic production of VLDL and LDL

21
Q

What is Niacin’s net effect?

A

BIG EFECTS:

- Decreased TGs, decreased LDL, and increased HDL

22
Q

What are Niacin’s main adverse effects?

A
  • Flushing, but tolerance will develop over time
  • P.U.D
  • Exacerbate gout
  • Exacerbate diabetes
  • Hepatotoxicity w/ ER formulation
23
Q

How should we monitor niacin?

A

Base line labs including: liver function tests, A1C and uric acid levels
- Labs should be repeated every 6 months

24
Q

What is Ezitimibe’s MOA?

A

Block cholesterol absorption by inhibiting NPC1L1 receptor at the brush boarder

25
What is Ezitimibe's net effect?
Decreased TC | Decreased LDL
26
What is Ezitimibe's main adverse effects?
Well tolerated, but can induce statin side effects when in combo.
27
What are the two main sources of omega-3 fatty acids?
DHA and EPA
28
What is omega-3 fatty acids MOA? What is different about DHA?
Both lower TGs, but DHA can increase LDL levels
29
What are the main side effects of omega-3 fatty acids?
GI disturbance, increased bleeding risk, and skin changes
30
What is lomitapide's MOA?
Blocks to MTP receptor and inhibits the assembly of ApoB lipoproteins, leading to a decrease in LDL production
31
What is Lomitapide main adverse effects?
Chest pain, and hepatic distress (steatosis)
32
What is the MOA of Mipomersen? What what is its black box warning?
MOA: Oligonucleotide inhibitor of Apo-B synthesis, decreasing LDL synthesis Black box warning: liver function, watching for elevated LFTs
33
What are mipomersen's maid adverse effects?
Injection site rxn (subQ injections), flu-like reactions (fatigue, headache, fever)
34
What is Evolocumabs MOA?
PCSK-9 inhibitor, allows for more LDL receptors to be placed on the membrane of cells, increasing LDL intake and decreasing circulating LDL levels
35
What are the main changes to the ACC/AHA guidelines? | Hint, there's 6
1. 4 groups named that would benefit from statin therapy 2. New perspective on LDL and non-HLD treatment goals 3. Global risk assessment for primary prevention 4. Updated safety recommendations 5. Role of biomarkers and noninvasive tests 6. Future updates to cholesterol guidelines
36
MUST KNOW THIS! | What are the 4 statin benefit groups?
1. Individuals w/ clinical ASCVD >21yrs old 2. Individuals w/ LDL >190 mg/dL and >21 yrs old 3. Individuals 40-75 yrs old w/ diabetes and LDL between 70-189 mg/dL 4. Individuals 40-75 yrs old w/ LDL 70-189 mg/dL and an estimated 10 year ASCVD risk >7.5% (basically everyone else who is high needs a statin)
37
What is the definition of ASCVD? | PASS to a statin
P: peripheral artery disease A: acute coronary syndromes (MI, angina) S: stent; coronary revascularization S: stroke and TIA
38
In the new global risk assessment for primary prevention what are the two event predicted and the 8 risk factors assessed?
Events: nonfatal/fatal MI or nonfatal/fatal stroke | Risk factors: sex, age, TC, HDL, systolic BP (Tx, Y or N), smoking (Y or N), race (white/other or AA), diabetes (Y or N)
39
Epidemiology of Hyperlipidemia
- TCs and LDLs increase throughout life - Almost half of Americans > 20 yrs have a TC >200mg/dL - Half of those at boarder line for high risk are unaware they have hypercholesterolemia